Carlos Perez-Sanchez
Overview
Explore the profile of Carlos Perez-Sanchez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
702
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanchez-Mendoza L, Perez-Sanchez C, Garcia-Caballero C, Perez-Rodriguez M, Calero-Rodriguez P, Vellon-Garcia B, et al.
Free Radic Biol Med
. 2024 Jul;
223:69-86.
PMID: 39069267
There is a pressing need to develop new strategies for enhancing health in the elderly and preventing the rise in age-related diseases. Calorie restriction without malnutrition (CR) stands among the...
2.
Munoz-Barrera L, Perez-Sanchez C, Ortega-Castro R, Corrales S, Luque-Tevar M, Cerdo T, et al.
Biomed Pharmacother
. 2024 Mar;
173:116357.
PMID: 38479179
Background & Objectives: This study aimed to: 1) analyze the inflammatory profile of Rheumatoid Arthritis (RA) patients, identifying clinical phenotypes associated with cardiovascular (CV) risk; 2) evaluate biologic and targeted-synthetic...
3.
Cuesta-Lopez L, Escudero-Contreras A, Hanaee Y, Perez-Sanchez C, Ruiz-Ponce M, Martinez-Moreno J, et al.
Front Immunol
. 2024 Feb;
15:1333995.
PMID: 38420123
Introduction: RA patients are at higher risk of cardiovascular disease, influenced by therapies. Studying their cardiovascular and cardiometabolic proteome can unveil biomarkers and insights into related biological pathways. Methods: This...
4.
Lopez-Pedrera C, Cerdo T, Jury E, Munoz-Barrera L, Escudero-Contreras A, Aguirre M, et al.
Rheumatology (Oxford)
. 2024 Feb;
63(SI):SI14-SI23.
PMID: 38320594
APS patients exhibit a wide clinical heterogeneity in terms of the disease's origin and progression. This diversity can be attributed to consistent aPL profiles and other genetic and acquired risk...
5.
Sanchez-Mendoza L, Perez-Sanchez C, Rodriguez-Lopez S, Lopez-Pedrera C, Calvo-Rubio M, de Cabo R, et al.
Free Radic Biol Med
. 2023 Jul;
207:144-160.
PMID: 37463636
Cytochrome b reductase 3 (CYB5R3) activates respiratory metabolism in cellular systems and exerts a prolongevity action in transgenic mice overexpressing this enzyme, mimicking some of the beneficial effects of calorie...
6.
Lopez-Pedrera C, Oteros R, Ibanez-Costa A, Luque-Tevar M, Munoz-Barrera L, Barbarroja N, et al.
J Thromb Haemost
. 2023 Apr;
21(10):2894-2907.
PMID: 37100394
Background: Nowadays little is known about the molecular profile of the occluding thrombus of patients with ischemic stroke. Objectives: To analyze the proteomic profile of thrombi in patients who experienced...
7.
Perez-Sanchez C, Escudero-Contreras A, Cerdo T, Sanchez-Mendoza L, Llamas-Urbano A, Arias-de la Rosa I, et al.
Arthritis Rheumatol
. 2023 Apr;
75(10):1749-1761.
PMID: 37094367
Objective: We analyzed NAD metabolism in patients with rheumatoid arthritis (RA), its association with disease activity and clinical outcomes of RA, and the therapeutic potential of pharmacologic NAD boosting. Methods:...
8.
Barbarroja N, Lopez-Montilla M, Cuesta-Lopez L, Perez-Sanchez C, Ruiz-Ponce M, Lopez-Medina C, et al.
Front Immunol
. 2023 Apr;
14:1133435.
PMID: 37033920
Objectives: 1) To characterize the inflammatory proteome of synovial fluid (SF) from patients with Psoriatic Arthritis (PsA) using a high-quality throughput proteomic platform, and 2) to evaluate its potential to...
9.
Perez-Sanchez C, Pineda-Torra I, Lopez-Pedrera C
Front Immunol
. 2022 Dec;
13:1085875.
PMID: 36505478
No abstract available.
10.
Barbarroja N, Ruiz-Ponce M, Cuesta-Lopez L, Perez-Sanchez C, Lopez-Pedrera C, Arias-de la Rosa I, et al.
Front Immunol
. 2022 Oct;
13:997270.
PMID: 36211332
Liver disease is one of the most important causes of morbidity and mortality worldwide whose prevalence is dramatically increasing. The first sign of hepatic damage is inflammation which could be...